Search results
150 fighters, cancer survivors march in 16th annual Kentucky Oaks Day Survivors Parade
WAVE 3 Louisville· 4 days agoOn Friday, 150 survivors and fighters of breast and ovarian cancer will march in the annual...
'Really powerful' | 150 resilient women walked in the Kentucky Oaks Survivors Parade
WDRB 41 Louisville News· 3 days agoEach survivor has survived ovarian cancer or breast cancer.
Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits
KTBS Shreveport· 5 days agoJohnson & Johnson announced Wednesday that it would pay out more than $6.5 billion over the next 25...
J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
KRQE & KASA FOX 2 Albuquerque· 6 days agoA subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years...
Mother rings 'Cancer Bell' to celebrate victory over ovarian cancer
Channel 8 San Diego· 17 hours agoWhen a patient beats cancer, oftentimes, they ring a bell to symbolize their victory. In this Zevely...
Johnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuits
CNN Business via AOL· 6 days agoJohnson & Johnson is moving forward with a proposed settlement of tens of thousands of lawsuits...
J&J proposing to pay $6.5B to resolve almost all talc ovarian cancer suits
The Hill via AOL· 5 days agoA subsidiary of Johnson & Johnson (J&J) is proposing to pay nearly $6.5 billion to resolve nearly...
J&J advances $6.48 billion settlement of talc cancer lawsuits
Reuters via Yahoo News· 6 days agoNEW YORK(Reuters) -Johnson & Johnson said on Wednesday it is moving forward with a $6.48 billion...
AstraZeneca’s Lynparza to remain dominant in PARP inhibitors market with $4 billion in sales by 2027
BioPharma-Reporter· 27 minutes agoWhile the PARP inhibitors market has seen increasing competition over the years, Lynparza is set to...
Scientists discover important link between diet and cancer risk
The Independent via Yahoo News· 18 hours agoThey also showed that cells from people at a high risk of developing breast or ovarian cancer –...